Sonoma Pharmaceuticals Share Price Today
(NASDAQ: SNOA)

Name: Sonoma Pharmaceuticals Share Price Today (NASDAQ: SNOA) - Sonoma Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Sonoma Pharmaceuticals share price is $2.13 & ₹185.24 as on 6 Mar 2025, 2.30 'hrs' IST

$2.13

▲

0.02

(0.95%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Sonoma Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Sonoma Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sonoma Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Sonoma Pharmaceuticals share price movements

Today's Low: $2.05
Today's High: $2.23
$2.13
3.75%
Downside
Day's Volatility :8.04%
Upside
4.46%
52 Weeks Low: $2.09
52 Weeks High: $9.37
$2.13
1.88%
Downside
52 Weeks Volatility :77.7%
Upside
77.28%

Sonoma Pharmaceuticals (SNOA) Returns

Period	Sonoma Pharmaceuticals Inc	Index (Russel 2000)
3 Months	-18.53%	0.0%
6 Months	-33.23%	0.0%
1 Year	-31.85%	0.0%
3 Years	-96.02%	-11.6%

Sonoma Pharmaceuticals (SNOA) Key Statistics

in dollars & INR

Previous Close	$2.11
Open	$2.09
Today's High	$2.2294
Today's Low	$2.0501
Market Capitalization	$3.4M
Today's Volume	$953.0
52 Week High	$9.374
52 Week Low	$2.0501
Revenue TTM	$14.0M
EBITDA	$-4.3M
Earnings Per Share (EPS)	$-2.28
Profit Margin	-26.82%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-64.83%

How to invest in Sonoma Pharmaceuticals Stock (SNOA) from India?

It is very easy for Indian residents to invest directly in Sonoma Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sonoma Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sonoma Pharmaceuticals or SNOA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sonoma Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sonoma Pharmaceuticals shares which would translate to 0.408 fractional shares of Sonoma Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sonoma Pharmaceuticals, in just a few clicks!

Returns in Sonoma Pharmaceuticals (SNOA) for Indian investors in Rupees

The Sonoma Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Sonoma Pharmaceuticals investment value today

Current value as on today

₹73,672

Returns

₹26,328

(-26.33%)

Returns from Sonoma Pharmaceuticals Stock

₹31,290 (-31.29%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Sonoma Pharmaceuticals (SNOA)

40%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Sonoma Pharmaceuticals Stock from India on INDmoney has increased by 40% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Sonoma Pharmaceuticals

UBS Group AG
1.08%
Tower Research Capital LLC
0.15%
JPMorgan Chase & Co
0.01%
BlackRock Inc
0.01%

Analyst Recommendation on Sonoma Pharmaceuticals

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Sonoma Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Sonoma Pharmaceuticals Stock (SNOA)

What analysts predicted

Upside of 698.12%

Target:

$17.00

Current:

$2.13

Insights on Sonoma Pharmaceuticals Stock (Ticker Symbol: SNOA)

Price Movement
In the last 3 years, SNOA stock has moved down by -96.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 3.57M → 3.56M (in $), with an average decrease of 0.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -610.0K → -928.0K (in $), with an average decrease of 52.1% per quarter
SNOA vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 97.0% return, outperforming this stock by 129.8%
SNOA vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 138.2% return, outperforming this stock by 234.6%
Price to Sales
ForSNOA every $1 of sales, investors are willing to pay $0.2, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

Sonoma Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Sonoma Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Sonoma Pharmaceuticals (SNOA) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sonoma Pharmaceuticals Inc	-18.22%	-33.23%	-31.85%	-96.02%	-97.9%
Intra-cellular Therapies, Inc.	3.42%	81.22%	98.76%	146.55%	588.92%
Haleon Plc Spon Ads	12.55%	3.39%	28.09%	43.99%	43.99%
Zoetis Inc.	-1.19%	-8.94%	-7.43%	-9.67%	30.97%
Neurocrine Biosciences Inc.	-24.64%	-6.68%	-14.47%	28.61%	27.88%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sonoma Pharmaceuticals Inc	NA	NA	0.0	0.0	-0.65	-0.2	NA	3.01
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	26.68	26.68	1.5	0.36	0.09	0.04	0.02	1.8
Zoetis Inc.	31.17	31.17	3.01	6.07	0.51	0.15	0.01	10.64
Neurocrine Biosciences Inc.	34.8	34.8	0.27	6.47	0.14	0.1	NA	26.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sonoma Pharmaceuticals Inc	Buy	$3.4M	-97.9%	NA	-26.82%
Intra-cellular Therapies, Inc.	Buy	$14.0B	588.92%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$48.2B	43.99%	26.68	12.84%
Zoetis Inc.	Buy	$76.1B	30.97%	31.17	26.86%
Neurocrine Biosciences Inc.	Buy	$11.3B	27.88%	34.8	14.49%

About Sonoma Pharmaceuticals

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. The company offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis; and Pediacyn, an atopic dermatitis hydrogel. It also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, the company offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, an antimicrobial prescription solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns for use in emergencies and on mucous membranes, cuts, abrasions, burns, and body surfaces; and Endocyn root canal irrigation solutions. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.

Organization	Sonoma Pharmaceuticals
Employees	10
CEO	Ms. Amy M. Trombly J.D.
Industry	Health Technology

Management People of Sonoma Pharmaceuticals

Name	Title
Ms. Amy M. Trombly J.D.	CEO, President & Director
Mr. Jerome J. Dvonch CPA	Chief Financial Officer
Mr. Bruce Thornton	Executive VP, COO & Corporate Secretary
Mr. John Dal Poggetto	Controller

Important FAQs about investing in SNOA Stock from India :

What is Sonoma Pharmaceuticals share price today?

Sonoma Pharmaceuticals share price today stands at $2.13, Open: $2.09 ; Previous Close: $2.11 ; High: $2.23 ; Low: $2.05 ; 52 Week High: $9.37 ; 52 Week Low: $2.09.

The stock opens at $2.09, after a previous close of $2.11. The stock reached a daily high of $2.23 and a low of $2.05, with a 52-week high of $9.37 and a 52-week low of $2.09.

Can Indians buy Sonoma Pharmaceuticals shares?

Yes, Indians can invest in the Sonoma Pharmaceuticals (SNOA) from India.

With INDmoney, you can buy Sonoma Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Sonoma Pharmaceuticals at zero transaction cost.

How can I buy Sonoma Pharmaceuticals shares from India?

It is very easy to buy Sonoma Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sonoma Pharmaceuticals (SNOA) be purchased?

Yes, you can buy fractional shares of Sonoma Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Sonoma Pharmaceuticals stocks?

To start investing in Sonoma Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.